Inmune Bio (INMB) Return on Assets [ROA] (2019 - 2026)
Inmune Bio (INMB) posted Return on Assets [ROA] of -76.70% for Q2 2026, up 72.29 percentage points from -148.98% a year earlier and up 72.15 percentage points from the prior quarter.
Powered by 
Analysis
Inmune Bio (INMB) Return on Assets [ROA] (2019 - 2026) Analysis & Trends
For FY2025, Inmune Bio's Return on Assets [ROA] came in at -131.78%, down 43.47 percentage points from FY2024.
- Annual Return on Assets [ROA] has declined for three consecutive years, with a five-year change of -94.23 percentage points (FY2020 to FY2025).
- In prior years, Inmune Bio's Return on Assets [ROA] was -88.31% in FY2024 (-45.45 pp), -42.86% in FY2023 (-14.30 pp), -28.56% in FY2022 (+12.91 pp) and -41.47% in FY2021 (-3.92 pp).
- The Q2 2026 figure stands as the highest quarterly Return on Assets [ROA] since Q2 2024.
- On a year-over-year basis, Return on Assets [ROA] increased in 1 of the last eight quarters, with an average year-over-year change of -35.21 percentage points.
- The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q2 2026, with a gain of 72.29 percentage points; the weakest was Q2 2025, with a drop of 72.86 percentage points.
- According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -148.84% (Q1 2026), -144.22% (Q4 2025) and -144.64% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 10.47% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 4.65% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.45% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 28.37% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 9.10% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 9.29% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -6.13% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.14% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 16.34% |
| 10 | Inmune Bio | 53.92 Mn | -38.33 Mn | - | -76.70% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -76.70% |
| Mar 31, 2026 | -148.84% |
| Dec 31, 2025 | -144.22% |
| Sep 30, 2025 | -144.64% |
| Jun 30, 2025 | -148.98% |
| Mar 31, 2025 | -107.35% |
| Dec 31, 2024 | -92.34% |
| Sep 30, 2024 | -78.96% |
| Jun 30, 2024 | -76.12% |
| Mar 31, 2024 | -66.13% |
| Dec 31, 2023 | -49.69% |
| Sep 30, 2023 | -40.79% |
| Jun 30, 2023 | -36.07% |
| Mar 31, 2023 | -33.25% |
| Dec 31, 2022 | -31.86% |
| Sep 30, 2022 | -34.69% |
| Jun 30, 2022 | -34.41% |
| Mar 31, 2022 | -32.43% |
| Dec 31, 2021 | -28.09% |
| Sep 30, 2021 | -27.72% |
API Access
Inmune Bio Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=INMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "INMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=INMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();